- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-PBXIP1
PBXIP1 Polyclonal Antibody for WB, IP, IF, IHC, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (1)
Applications
WB, IHC, IF/ICC, IP, chIP, ELISA
Conjugaison
Non conjugué
N° de cat : 12102-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules BxPC-3, cellules A549, cellules HeLa |
Résultats positifs en IP | cellules HeLa |
Résultats positifs en IHC | tissu de cancer du poumon humain, il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF/ICC | cellules HepG2, cellules HeLa |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 6 publications below |
WB | See 9 publications below |
IHC | See 5 publications below |
IF | See 3 publications below |
ChIP | See 1 publications below |
Informations sur le produit
12102-1-AP cible PBXIP1 dans les applications de WB, IHC, IF/ICC, IP, chIP, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | PBXIP1 Protéine recombinante Ag2746 |
Nom complet | pre-B-cell leukemia homeobox interacting protein 1 |
Masse moléculaire calculée | 731 aa, 81 kDa |
Poids moléculaire observé | 95-100 kDa |
Numéro d’acquisition GenBank | BC016852 |
Symbole du gène | PBXIP1 |
Identification du gène (NCBI) | 57326 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
PBXIP1 (pre-B-cell leukemia transcription factor-interacting protein 1), also known as HPIP (hematopoietic PBX-interacting protein), is a regulator of pre-B-cell leukemia transcription factors (BPXs) function. PBXIP1 is a nucleo-cytoplasmic shuttling protein, mainly localized in the cytosol and in small amounts in the nucleus (PMID: 10825160). It interacts with PBX1 as well as PBX2 and PBX3. PBXIP1 inhibits the ability of PBX-HOX heterodimers to bind to target sequences and strongly inhibits the transactivation activity of E2A-PBX. PBXIP1 is also reported to be a microtubule-binding protein, which regulates estrogen receptor functions and plays a role in cancer development and progression (PMID: 17043237; 18302941; 23321675). The predicted PBXIP1 protein has a calculated molecular mass of 81 kDa. This polyclonal antibody raised against 1-300aa of human PBXIP1 recognizes endogenous PBXIP1 with an apparent molecular weight of 95-100 kDa. The slow migration of PBXIP1 possibly results from either post-translational modifications or intrinsic SDS-resistant folding of the protein (PMID: 10825160; 17043237).
Protocole
Product Specific Protocols | |
---|---|
WB protocol for PBXIP1 antibody 12102-1-AP | Download protocol |
IHC protocol for PBXIP1 antibody 12102-1-AP | Download protocol |
IF protocol for PBXIP1 antibody 12102-1-AP | Download protocol |
IP protocol for PBXIP1 antibody 12102-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
J Clin Invest Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.
| ||
Cell Death Differ MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation. | ||
Oncogenesis The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway.
| ||
Cancer Sci Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
| ||
Sci Rep HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion. | ||
IUBMB Life HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.
|